LUNAR
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Sept 2024)
What this means for you
Registered since 03 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86170462
- Registration number
- 5438472
- Mark type
- Stylized text
- Filed
- 21 Jan 2014
- Published for opposition
- 06 Jan 2015
- Registered
- 03 Apr 2018
- Attorney of record
- Gabrial L. Mitchell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome, sold to pharmaceutical companies as an integral component for use in the further manufacture of pharmaceutical preparations for the treatment of a wide variety of diseases, including rare and orphan diseases
Owner
- Arcturus Therapeutics, Inc., San Diego, CA, US
- Arcturus Therapeutics, Inc., San Diego, CA, US
- Arcturus Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 27 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Sept 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Mar 2024 — TEAS SECTION 8 & 15 RECEIVED
- 03 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 02 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Mar 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Feb 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Feb 2018 — USE AMENDMENT FILED
- 12 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 06 Sept 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2017 — SOU EXTENSION 5 GRANTED
- 31 Aug 2017 — SOU EXTENSION 5 FILED
- 31 Aug 2017 — SOU TEAS EXTENSION RECEIVED